Daryl C Drummond - Net Worth and Insider Trading
Daryl C Drummond Net Worth
The estimated net worth of Daryl C Drummond is at least $153,917 dollars as of 2024-09-20. Daryl C Drummond is the Head of Research of Merrimack Pharmaceuticals Inc and owns about 10,173 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $153,917. Details can be seen in Daryl C Drummond's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daryl C Drummond has not made any transactions after 2017-05-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daryl C Drummond
Daryl C Drummond Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daryl C Drummond owns 1 companies in total, including Merrimack Pharmaceuticals Inc (MACK) .
Click here to see the complete history of Daryl C Drummond’s form 4 insider trades.
Insider Ownership Summary of Daryl C Drummond
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2017-05-12 | Head of Research |
Daryl C Drummond Latest Holdings Summary
Daryl C Drummond currently owns a total of 1 stock. Daryl C Drummond owns 10,173 shares of Merrimack Pharmaceuticals Inc (MACK) as of May 12, 2017, with a value of $153,917.
Latest Holdings of Daryl C Drummond
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2017-05-12 | 10,173 | 15.13 | 153,917 |
Holding Weightings of Daryl C Drummond
Daryl C Drummond Form 4 Trading Tracker
According to the SEC Form 4 filings, Daryl C Drummond has made a total of 0 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years. The most-recent trade in Merrimack Pharmaceuticals Inc is the sale of 410 shares on May 12, 2017, which brought Daryl C Drummond around $15,241.
Insider Trading History of Daryl C Drummond
- 1
Daryl C Drummond Trading Performance
Daryl C Drummond Ownership Network
Daryl C Drummond Owned Company Details
What does Merrimack Pharmaceuticals Inc do?
Who are the key executives at Merrimack Pharmaceuticals Inc?
Daryl C Drummond is the Head of Research of Merrimack Pharmaceuticals Inc. Other key executives at Merrimack Pharmaceuticals Inc include director & other: See Remarks Eric Andersen , director & President Gary L Crocker , and director & other: See Remarks Noah G. Levy .
Merrimack Pharmaceuticals Inc (MACK) Insider Trades Summary
Over the past 18 months, Daryl C Drummond made no insider transaction in Merrimack Pharmaceuticals Inc (MACK). Other recent insider transactions involving Merrimack Pharmaceuticals Inc (MACK) include a net purchase of 607,008 shares made by Eric Andersen , and a net purchase of 4,000 shares made by Gary L Crocker .
In summary, during the past 3 months, insiders sold 0 shares of Merrimack Pharmaceuticals Inc (MACK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merrimack Pharmaceuticals Inc (MACK) were sold and 611,008 shares were bought by its insiders, resulting in a net purchase of 611,008 shares.
Merrimack Pharmaceuticals Inc (MACK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merrimack Pharmaceuticals Inc Insider Transactions
Daryl C Drummond Mailing Address
Above is the net worth, insider trading, and ownership report for Daryl C Drummond. You might contact Daryl C Drummond via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
